- Incorporates important mathematical models and computational applications- Includes unique content on central composite design and augmented simplex lattice- Provides background on important design principles with emphasis on quality-based design (QBD) of pharmaceutical dosage forms
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Chapter 1 Introduction
1.1 General Considerations 1.2 Particle Sizes 1.3 Excipients 1.4 Mixing of Pharmaceutical Powders 1.5 Statistical Methods 1.6 Equipment
Chapter 2 Rapid Release Tablets
2.1 Low dose tablet by Direct Compression 2.2 High Dose Tablet by Direct Compression 2.3 Insoluble API, Low Dose Tablet by Wet Granulation 2.4 Soluble API, Low Dose Tablet by Wet Granulation 2.5 Insoluble API, High Dose Tablet by Wet Granulation 2.6 Soluble API, High Dose Tablet by Wet Granulation
Chapter 3 Sustained Release (SR) Tablets
3.1 SR Tablet Using a Lipid Release Control Agent 3.2 SR Tablet Using HPMC/Eudragit 3.3 SR Tablet Using HPMC Mixtures
Dr. Eyjolfsson entered pharmacy in 1959, having studied at the University of Iceland and then at the Pharmaceutical University of Denmark, Copenhagen 1961-1964 (MsPharm 1964). Dr. Eyjolfsson earned a Ph.D. in the chemistry of natural product from same university in 1968. He moved to Iceland in 1971 and has worked with drug formulation science at Pharmaco, Delta, Actavis until 2010. Dr. Eyjolfsson is an author of approximately 30 scientific papers in peer reviewed journals mainly on phytochemistry and pharmaceutics. He has designed many different dosage forms but mostly conventional tablets and slow release tablets.